Jonathan Sockolosky, PhDScientist, Department of Antibody Engineering at Genentech
Jonathan Sockolosky received his BS/MS in Biomedical Engineering from the University of Michigan, his PhD in Pharmaceutical Sciences from UCSF, and did postdoctoral research at Stanford in the lab of K. Christopher Garcia where he invented orthogonal IL-2 cytokine-receptor pairs for cell therapy under development by Synthekine. Previously Jonathan was a Principal Scientist at ALX Oncology, a clinical stage biotechnology company developing CD47/SIRPa antagonists for cancer immunotherapy. Currently Jonathan is a Scientist in the Department of Antibody Engineering at Genentech. His research group is focused on the development of next generation immune modulating therapeutics for oncology and cancer immunology.